GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Affimed NV (NAS:AFMD) » Definitions » Cyclically Adjusted Revenue per Share

Affimed NV (Affimed NV) Cyclically Adjusted Revenue per Share : $3.17 (As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is Affimed NV Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Affimed NV's adjusted revenue per share for the three months ended in Dec. 2023 was $0.030. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $3.17 for the trailing ten years ended in Dec. 2023.

During the past 12 months, Affimed NV's average Cyclically Adjusted Revenue Growth Rate was -5.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2024-06-10), Affimed NV's current stock price is $6.105. Affimed NV's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was $3.17. Affimed NV's Cyclically Adjusted PS Ratio of today is 1.93.

During the past 12 years, the highest Cyclically Adjusted PS Ratio of Affimed NV was 6.52. The lowest was 0.91. And the median was 1.90.


Affimed NV Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Affimed NV's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Affimed NV Cyclically Adjusted Revenue per Share Chart

Affimed NV Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 3.34 3.17

Affimed NV Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.34 3.46 3.47 3.50 3.17

Competitive Comparison of Affimed NV's Cyclically Adjusted Revenue per Share

For the Biotechnology subindustry, Affimed NV's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Affimed NV's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Affimed NV's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Affimed NV's Cyclically Adjusted PS Ratio falls into.



Affimed NV Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Affimed NV's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.03/123.7729*123.7729
=0.030

Current CPI (Dec. 2023) = 123.7729.

Affimed NV Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 0.417 99.543 0.519
201406 0.420 99.543 0.522
201409 1.017 99.823 1.261
201412 0.042 99.543 0.052
201503 1.111 99.717 1.379
201506 0.909 100.417 1.120
201509 0.427 100.417 0.526
201512 0.542 99.717 0.673
201603 0.637 100.017 0.788
201606 0.694 100.717 0.853
201609 0.317 101.017 0.388
201612 0.428 101.217 0.523
201703 0.105 101.417 0.128
201706 0.129 102.117 0.156
201709 0.124 102.717 0.149
201712 0.167 102.617 0.201
201803 0.120 102.917 0.144
201806 0.028 104.017 0.033
201809 0.057 104.718 0.067
201812 4.145 104.217 4.923
201903 2.055 104.217 2.441
201906 0.725 105.718 0.849
201909 0.371 106.018 0.433
201912 0.572 105.818 0.669
202003 0.744 105.718 0.871
202006 0.417 106.618 0.484
202009 1.444 105.818 1.689
202012 1.283 105.518 1.505
202103 1.194 107.518 1.375
202106 0.977 108.486 1.115
202109 0.851 109.435 0.962
202112 0.955 110.384 1.071
202203 0.714 113.968 0.775
202206 0.524 115.760 0.560
202209 0.987 118.818 1.028
202212 0.791 119.345 0.820
202303 0.323 122.402 0.327
202306 0.101 123.140 0.102
202309 0.140 124.195 0.140
202312 0.030 123.773 0.030

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Affimed NV  (NAS:AFMD) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Affimed NV's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=6.105/3.17
=1.93

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 12 years, the highest Cyclically Adjusted PS Ratio of Affimed NV was 6.52. The lowest was 0.91. And the median was 1.90.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Affimed NV Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Affimed NV's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Affimed NV (Affimed NV) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Affimed NV (NAS:AFMD) » Definitions » Cyclically Adjusted Revenue per Share
Traded in Other Exchanges
Address
Im Neuenheimer Feld 582, Technologiepark, Heidelberg, BW, DEU, 69120
Affimed NV is a clinical-stage biopharmaceutical company. The company is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an approach to cancer treatment that seeks to harness the body's immune defenses to fight tumor cells. The company is also developing single and combination therapies to treat cancers and other life-threatening diseases. Geographically, it derives a majority of revenue from the United States and also has a presence in Europe and Germany.

Affimed NV (Affimed NV) Headlines

From GuruFocus